Updates are available Correction dated 2020-02-24
Click to view Correction: https://doi.org/10.1007/s40883-020-00152-4
-
Authors
-
Funding
Funding for this research was provided by:
National Eye Institute (EY023427)
Research to Prevent Blindness (Hamilton Eye Institute)
- License Information
-
More Information
Article History
Received: 29 March 2018
Accepted: 15 June 2018
First Online: 29 June 2018
Change Date: 24 February 2020
Change Type: Correction
Change Date: 24 February 2020
Change Type: Correction
Change Details: An affiliation for Dr. Sally L. Elshaer was inadvertently omitted from this paper:Department of Pharmacology and Toxicology, College of Pharmacy, Mansoura University, 60 Elgomhoria St, Mansoura, 35516, Egypt
Change Details: An affiliation for Dr. Sally L. Elshaer was inadvertently omitted from this paper:
Compliance with Ethical Standards
: Human ASC culture studies were approved for research per the University of Tennessee Institutional Biosafety and Institutional Review Board as exempt study.
: RG is a co-founder and hold equity in Cell Care Therapeutics Inc., whose interest is in the use of adipose-derived stromal cells in visual disorders. None of the other authors declare any financial conflicts.
